Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03781518
Other study ID # 290316
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 1, 2018
Est. completion date July 1, 2018

Study information

Verified date December 2018
Source Cairo University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Mandibular ridge splitting with complete separation of the buccal cortical plate versus Khoury shell technique for horizontal augmentation of atrophic posterior mandible


Recruitment information / eligibility

Status Completed
Enrollment 22
Est. completion date July 1, 2018
Est. primary completion date July 1, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years to 60 Years
Eligibility Inclusion Criteria:

- Patients with atrophic mandible with residual bone width 3 to 4 mm.

- Both sexes.

- No intraoral soft and hard tissue pathology

- No systemic condition that contraindicate implant placement.

Exclusion Criteria:

- • Any pathology in the posterior mandible.

- Heavy smokers more than 20 cigarettes per day.

- Patients with systemic disease that may affect normal healing.

- Psychiatric problems

- Disorders to implant are related to history of radiation therapy to the head and neck neoplasia, or bone augmentation to implant site.

Study Design


Related Conditions & MeSH terms

  • Atrophy
  • Horizontal Augmentation of Atrophic Posterior Mandible

Intervention

Procedure:
ridge splitting in group and khoury shell technique in the other group
Mandibular ridge splitting with complete separation of the buccal cortical plate for horizontal augmentation of atrophic posterior mandible in one group and the other group will receive khoury shell technique by taking bone block from the ramus

Locations

Country Name City State
Egypt Cairo University Cairo

Sponsors (1)

Lead Sponsor Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Amount of horizontal bone gain (bone width) measurement using CBCT 4 months
Secondary Soft tissue healing Dehiscence or no dehiscence 1 months